Consequences of Prior Use of Full-dose Ritonavir as Single Protease Inhibitor as Part of Combination Antiretroviral Regimens on the Future Therapy Choices in HIV-1–Infected Children

Ute D. Feucht, Theresa Rossouw, Gisela Van Dyk, Brian Forsyth, Mariana Kruger
  • The Pediatric Infectious Disease Journal, February 2014, Wolters Kluwer Health
  • DOI: 10.1097/inf.0b013e31829f2694

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Dr Ute Feucht